Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates.
Kizzmekia S CorbettAnne P WernerSarah O' ConnellMatthew GagneLilin LaiJuan I MolivaBarbara FlynnAngela ChoiMatthew KochKathryn E FouldsShayne F AndrewDillon R FlebbeEvan LambSaule T NurmukhambetovaSamantha J ProvostKevin W BockMahnaz MinaiBianca M NagataAlex Van RyZackery FlinchbaughTimothy S JohnstonElham Bayat MokhtariPrakriti MudvariAmy R HenryFarida LabouneBecky ChangMaciel PortoJaclyn WearGabriela S AlvaradoSeyhan Boyoglu-BarnumJohn-Paul M ToddBridget BartAnthony CookAlan DodsonLaurent PessaintKatelyn SteingrebeSayda ElbashirHanne AndersenKai WuDarin K EdwardsSwagata KarMark G LewisEli BortizIan N MooreAndrea CarfiMehul S SutharAdrian McDermottMario RoedererMartha C NasonNancy J SullivanDaniel C DouekBarney S GrahamRobert A SederPublished in: bioRxiv : the preprint server for biology (2021)
Immunization with two doses of mRNA-1273 achieves effective immunity that rapidly controls lower and upper airway viral replication against the B.1.351 variant in NHP.